期刊文献+

表观遗传调控防治移植物抗宿主病的研究进展

原文传递
导出
摘要 移植物抗宿主病(graft versus host disease,GVHD)是骨髓/造血干细胞移植(bone marrow/hematopoietic stem cell transplantation,BMT/HSCT)主要并发症之一,是影响BMT/HSCT后长期存活的重要因素。近年来研究表明,表观遗传修饰包括组蛋白去乙酰化、组蛋白甲基化和DNA甲基化在GVHD的发生发展中起着重要作用,组蛋白去乙酰化酶抑制剂、组蛋白甲基化酶抑制剂和DNA甲基化酶抑制剂能有效预防或治疗GVHD。因此,对表观遗传调控的研究将为GVHD预防和治疗提供新的思路和方法。
出处 《现代免疫学》 CAS CSCD 北大核心 2013年第4期328-332,共5页 Current Immunology
基金 国家自然基金青年科学项目(30901317)
  • 相关文献

参考文献36

  • 1Choi S,Reddy P. HDAC inhibition and graft versus host dis-ease[J]. Mol Med, 2011,17: 404-416.
  • 2BlazarBR,Murphy WJ , Abedi M. Advances in graft-versus-host disease biology and therapy [ J]. Nat Rev Immunol,2012,12: 443-458.
  • 3Esteller M. Cancer epigenomics: DNA methylomes and his-tone-modification maps[J], Nat Rev Genet, 2007,8: 286-298.
  • 4Marks P,Rifkind RA, Richon VM, et al. Histone deacety-lases and cancer: causes and therapies[J]. Nat Rev Cancer,2001, 1: 194-202.
  • 5Wanczyk M, Roszczenko K,Marcinkiewicz K,et al. HDA-Ci-going through the mechanisms [J ]. Front Biosci,2011,16: 340-359.
  • 6Buchwald M, Kramer OH, Heinzel T. HDACi-targets be-yond chromatin[J]. Cancer Lett, 2009,280 : 160-167.
  • 7Mann BS, Johnson JR, Cohen MH, et al. FDA approvalsummary : vorinostat for treatment of advanced primary cuta-neous T-cell lymphoma [J]. Oncologist, 2007,12: 1247-1252.
  • 8Leoni F,Zaliani A, Bertolini G, et al. The antitumor histonedeacetylase inhibitor suberoylanilide hydroxamic acid exhibitsantiinflammatory properties via suppression of cytokines[J].Proc Natl Acad Sci USA, 2002,99: 2995-3000.
  • 9Glauben R, Batra A,Fedke I,et al. Histone hyperacetyla-tion is associated with amelioration of experimental colitis inmice[J]. J Immunol, 2006,176 : 5015-5022.
  • 10Glauben R, Batra A,Stroh T,et al. Histone deacetylases:novel targets for prevention of colitis-associated cancer inmice[J], Gut, 2008,57: 613-622.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部